Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:1-hydroxyprotostemonine, (rel)-
go back to main search page
Accession:CHEBI:70405 term browser browse the term
Definition:An alkaloid that has formula C23H31NO7.
Synonyms:related_synonym: (5Z)-5-{(1S,3aR,8S,10R,10aR,10bR)-10-Hydroxy-1-methyl-8-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene}-4-methoxy-3-methyl-2(5H)-furanone;   Formula=C23H31NO7;   InChI=1S/C23H31NO7/c1-10-8-16(30-22(10)26)13-9-14(25)18-17-11(2)20(29-15(17)6-5-7-24(13)18)21-19(28-4)12(3)23(27)31-21/h10-11,13-18,25H,5-9H2,1-4H3/b21-20-/t10-,11-,13-,14+,15+,16-,17-,18-/m0/s1;   InChIKey=PVVXZVZMHFPXJR-CJBCMZFDSA-N;   SMILES=[H][C@]1(C[C@H](C)C(=O)O1)[C@]1([H])C[C@@H](O)[C@]2([H])N1CCC[C@@]1([H])O\\C([C@@H](C)[C@]21[H])=C1OC(=O)C(C)=C/1OC
 xref: PMID:21049906 "Europe PMC"


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19669
    role 19613
      biological role 19611
        biochemical role 19138
          metabolite 19106
            1-hydroxyprotostemonine, (rel)- 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19669
    subatomic particle 19665
      composite particle 19665
        hadron 19665
          baryon 19665
            nucleon 19665
              atomic nucleus 19665
                atom 19665
                  main group element atom 19545
                    p-block element atom 19545
                      carbon group element atom 19428
                        carbon atom 19420
                          organic molecular entity 19420
                            heteroorganic entity 19003
                              organonitrogen compound 18076
                                alkaloid 5195
                                  1-hydroxyprotostemonine, (rel)- 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.